These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Synthesis and in vitro antitubercular activity of pyridine analouges against the resistant Mycobacterium tuberculosis. Patel H; Chaudhari K; Jain P; Surana S Bioorg Chem; 2020 Sep; 102():104099. PubMed ID: 32711084 [TBL] [Abstract][Full Text] [Related]
47. Synthesis of novel [1,2]-diamines with antituberculosis activity. Meng Q; Luo H; Chen Y; Wang T; Yao Q Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and antitubercular activity of heteroaromatic isonicotinoyl and 7-chloro-4-quinolinyl hydrazone derivatives. Ferreira Mde L; Gonçalves RS; Cardoso LN; Kaiser CR; Candea AL; Henriques Md; Lourenço MC; Bezerra FA; de Souza MV ScientificWorldJournal; 2010 Jul; 10():1347-55. PubMed ID: 20623095 [TBL] [Abstract][Full Text] [Related]
49. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents. Ramprasad J; Nayak N; Dalimba U Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841 [TBL] [Abstract][Full Text] [Related]
50. Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents. Fan YL; Wu JB; Ke X; Huang ZP Bioorg Med Chem Lett; 2018 Oct; 28(18):3064-3066. PubMed ID: 30119957 [TBL] [Abstract][Full Text] [Related]
51. The antitubercular activity of various nitro(triazole/imidazole)-based compounds. Papadopoulou MV; Bloomer WD; Rosenzweig HS Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives. Güzel O; Karali N; Salman A Bioorg Med Chem; 2008 Oct; 16(19):8976-87. PubMed ID: 18804379 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives. Seitz LE; Suling WJ; Reynolds RC J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027 [TBL] [Abstract][Full Text] [Related]
54. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents. Penta A; Franzblau S; Wan B; Murugesan S Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and antituberculosis activity of some new 2-quinoxalinecarbonitriles. Montoya ME; Sainz Y; Ortega MA; Lopez De Cerain A; Monge A Farmaco; 1998; 53(8-9):570-3. PubMed ID: 10081819 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and Anti-bacterial Activity of New Substituted 2-trifluoromethyl-4-quinolinylhydrazone Analogs against da Silva ET; de Andrade GF; Lourenço MCS; De Souza MVN Curr Med Chem; 2024; 31(40):6713-6721. PubMed ID: 39420718 [TBL] [Abstract][Full Text] [Related]
57. Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs. Sriram D; Yogeeswari P; Gopal G Eur J Med Chem; 2005 Dec; 40(12):1373-6. PubMed ID: 16129516 [TBL] [Abstract][Full Text] [Related]